What does hearing dysfunction have to do with an ophthalmology podcast? Listen up and find out as Dr. Drew Carey interviews Dr. Jamie A. Keen and Dr. Erin M. Shriver on the risks of using teprotumumab to hearing function in treatment of thyroid eye disease. From their article “Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab.”
Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab. Keen, Jamie A. et al. Ophthalmology, Volume 131, Issue 1, 30 – 36.
Podden och tillhörande omslagsbild på den här sidan tillhör American Academy of Ophthalmology. Innehållet i podden är skapat av American Academy of Ophthalmology och inte av, eller tillsammans med, Poddtoppen.
